Hey look they updated the OTC Markets page again (removed
Hey look they updated the OTC Markets page again (removed "Empact" as investor relations firm, and removed Accounting/Auditing Firm and Securities Council)... not sure who the "they" is who did it though... could have been OTC running an update script on currently available information for all I know.
http://www.otcmarkets.com/stock/SPCL/profile
Cached Version:
https://webcache.googleusercontent.com/search...&gl=de
Solaris Power Cells, Inc (SPCL) Stock Research Links
Disclaimer: Anything that I post on this board or any website (username "nine"
is an opinion, is provided for informational purposes only and is not intended for stock trading or investment purposes or to be used as stock trading or investment advice.
My Investment Strategy:
That’s 3,000 pennies a day; 21,000 pennies a week; 1,092,000 pennies a year! To date that’s 12,012,000 pennies, 8 times the population of Nebraska.
Click Here To View
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...
Continue Reading
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...
Continue Reading
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...
Continue Reading
Top 5 Most Recently Viewed Articles
Insights from APA Corporation's Q3 2024 Financial Update HOUSTON -- APA Corporation (Nasdaq: APA) has released key information regarding its third-quarter 2024 financial and operational results. This supplemental information serves as a guide for investors, analysts, and stakeholders to help them form their own estimates regarding the company's performance. Understanding...
Continue Reading
Insights on the US Coffee Market Growth The US coffee market is currently gearing up for an exciting decade ahead, with projections indicating it could reach USD 150.88 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.8% from 2025. This surge is largely influenced by shifting consumer preferences towards premium and specialty coffee, along with an...
Continue Reading
Understanding the Upcoming Earnings Announcement Great Lakes Dredge & Dock (NASDAQ: GLDD) is gearing up for its quarterly earnings report, and investors are eager to glean insights from the announcement. The anticipation is palpable as analysts forecast an earnings per share (EPS) of $0.09, signalling potential growth for the company. Market Reactions and Guidance It's...
Continue Reading
Calmére Estate Winery Changes Hands in Major Sale Napa Valley has long been a beacon for wine enthusiasts and savvy investors alike. The recent transaction involving Calmére Estate Winery showcases the continued potential of this iconic region. The winery, known for its exquisite Chardonnay and Pinot Noir, has been a part of the Carneros American Viticultural Area (AVA)...
Continue Reading
Mr. Splash Car Wash Takes a Strategic Step Forward Mr. Splash Car Wash, a notable name in the express car wash industry, has recently entered into a strategic partnership with NBA stars Giannis and Thanasis Antetokounmpo, along with Michael Carter-Williams. This collaboration aims to elevate the brand's presence in the Midwest, showcasing Mr. Splash's commitment to...
Continue Reading